Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PINDOLOL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 221 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Serretti, A; Zanardi, R; Rossini, D; Cusin, C; Lilli, R; Smeraldi, E
      Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity

      MOLECULAR PSYCHIATRY
    2. Meagher, KL; Mewshaw, RE; Evrard, DA; Zhou, P; Smith, DL; Scerni, R; Spangler, T; Abulhawa, S; Shi, XJ; Schechter, LE; Andree, TH
      Studies towards the next generation of antidepressants. Part 1: Indolylcyclohexylamines as potent serotonin reuptake inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    3. Serretti, A; Zanardi, R; Cusin, C; Rossini, D; Lorenzi, C; Smeraldi, E
      Tryptophan hydroxylase gene associated with paroxetine antidepressant activity

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    4. Martinez, D; Hwang, DR; Mawlawi, O; Slifstein, M; Kent, J; Simpson, N; Parsey, RV; Hashimoto, T; Huang, YY; Shinn, A; Van Heertum, R; Abi-Dargham, A; Caltabiano, S; Malizia, A; Cowley, H; Mann, JJ; Laruelle, M
      Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: A dose-occupancy study with [C-11]WAY 100635 and positron emission tomography in humans

      NEUROPSYCHOPHARMACOLOGY
    5. Kasamo, K; Suzuki, T; Tada, K; Ueda, N; Matsuda, E; Ishikawa, K; Kojima, T
      Endogenous 5-HT tonically inhibits spontaneous firing activity of dorsal hippocampus CA1 pyramidal neurons through stimulation of 5-HT1A receptors inquiet awake rats: In vivo electrophysiological evidence

      NEUROPSYCHOPHARMACOLOGY
    6. Miller, FE
      Strategies for the rapid treatment of depression

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    7. Artigas, F
      Limitations to enhancing the speed of onset of antidepressants - Are rapidaction antidepressants possible?

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    8. Gardier, AM; Trillat, AC; Malagie, I; David, D; Hascoet, M; Coombel, MC; Jolliet, P; Jacquot, C; Hen, R; Bourin, M
      5-MT1B receptors mediate the antidepressant effects of selective serotoninreuptake inhibitors.

      COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES
    9. Yu, GD; Liu, YL; Jiang, XH; Guo, SY; Zhang, HQ; Yin, QZ; Hisamitsu, T
      The inhibitory effect of serotonin on the spontaneous discharge of suprachiasmatic neurons in hypothalamic slice is mediated by 5-HT7 receptor

      BRAIN RESEARCH BULLETIN
    10. Gross, AS; McLachlan, AJ; Minns, I; Beal, JB; Tett, SE
      Simultaneous administration of a cocktail of markers to measure renal drugelimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    11. Monti, JM; Jantos, H; Monti, D
      Evidence of melatonin involvement in pindolol-induced suppression of REM sleep

      JOURNAL OF NEURAL TRANSMISSION
    12. Dursun, SM; Devarajan, S; Kutcher, S
      The 'Dalhousie Serotonin cocktail' for treatment-resistant major depressive disorder

      JOURNAL OF PSYCHOPHARMACOLOGY
    13. Caspi, N; Modai, I; Barak, P; Waisbourd, A; Zbarsky, H; Hirschmann, S; Ritsner, M
      Pindolol augmentation in aggressive schizophrenic patients: a double-blindcrossover randomized study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    14. Martinez, J; Perez, S; Oficialdegui, AM; Heras, B; Orus, L; Villanueva, H; Palop, JA; Roca, J; Mourelle, M; Bosch, A; Del Castillo, JC; Lasheras, B; Tordera, R; del Rio, J; Monge, A
      New 3-[4-(aryl)piperazin-1-yl]-1(benzo[b]thiophen3-yl) propane derivativeswith dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    15. McLachlan, AJ; Gross, AS; Beal, JL; Minns, I; Tett, SE
      Analytical validation for a series of marker compounds used to assess renal drug elimination processes

      THERAPEUTIC DRUG MONITORING
    16. Appelberg, BG; Syvalahti, EK; Koskinen, TE; Mehtonen, OP; Muhonen, TT; Naukkarinen, HH
      Patients with severe depression may benefit from buspirone augmentation ofselective serotonin reuptake inhibitors: Results from a placebo-controlled, randomized, double-blind, placebo wash-in study

      JOURNAL OF CLINICAL PSYCHIATRY
    17. Blier, P
      Pharmacology of rapid-onset antidepressant treatment strategies

      JOURNAL OF CLINICAL PSYCHIATRY
    18. Newman-Tancredi, A; Chaput, C; Touzard, M; Millan, MJ
      Pindolol antagonises G-protein activation at both pre- and postsynaptic serotonin 5-HT1A receptors: a [S-35]GTP gamma S autoradiography study

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    19. Cordi, AA; Berque-Bestel, I; Persigand, T; Lacoste, JM; Newman-Tancredi, A; Audinot, V; Millan, MJ
      Potential antidepressants displayed combined alpha(2)-adrenoceptor antagonist and monoamine uptake inhibitor properties

      JOURNAL OF MEDICINAL CHEMISTRY
    20. Martinez-Esparza, J; Oficialdegui, AM; Perez-Silanes, S; Heras, B; Orus, L; Palop, JA; Lasheras, B; Roca, J; Mourelle, H; Bosch, A; Del Castillo, JC; Tordera, R; Del Rio, J; Monge, A
      New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants

      JOURNAL OF MEDICINAL CHEMISTRY
    21. Horinouchi, T; Koike, K
      (+/-)-pindolol acts as a partial agonist at atypical beta-adrenoceptors inthe guinea pig duodenum

      JAPANESE JOURNAL OF PHARMACOLOGY
    22. Millan, MJ; Newman-Tancredi, A; Duqueyroix, D; Cussac, D
      Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase

      EUROPEAN JOURNAL OF PHARMACOLOGY
    23. Zanardi, R; Serretti, A; Rossini, D; Franchini, L; Cusin, C; Lattuada, E; Dotoli, D; Smeraldi, E
      Factors affecting fluvoxamine antidepressant activity: Influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

      BIOLOGICAL PSYCHIATRY
    24. Cremers, TIFH; Wiersma, LJ; Bosker, FJ; den Boer, JA; Westerink, BHC; Wikstrom, HV
      Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism?

      BIOLOGICAL PSYCHIATRY
    25. Bridge, MW; Marvin, G; Thompson, CE; Sharma, A; Jones, DA; Kendall, MJ
      Quantifying the 5-HT1 agonist action of buspirone in man

      PSYCHOPHARMACOLOGY
    26. Attenburrow, MJ; Mitter, PR; Whale, R; Terao, T; Cowen, PJ
      Low-dose citalopram as a 5-HT neuroendocrine probe

      PSYCHOPHARMACOLOGY
    27. Murck, H; Frieboes, RM; Antonijevic, IA; Steiger, A
      Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A agonist EMD 68843 on the sleep EEG in healthy men

      PSYCHOPHARMACOLOGY
    28. Passchier, J; van Waarde, A; Pierterman, RM; Willemsen, ATM; Vaalburg, W
      Quantifying drug-related 5-HT1A receptor occupancy with [F-18]MPPF

      PSYCHOPHARMACOLOGY
    29. Haddjeri, N; Blier, P
      Effects of sustained (+/-)pindolol administration on serotonin neurotransmission in rats

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    30. Niwa, H; Satoh, Y; Matsuura, H
      Cardiovascular responses to epinephrine-containing local anesthetics for dental use: A comparison of hemodynamic responses to infiltration anesthesiaand ergometer-stress testing

      ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
    31. Cowen, PJ
      Psychopharmacology of 5-HT1A receptors

      NUCLEAR MEDICINE AND BIOLOGY
    32. Passchier, J; van Waarde, A; Pieterman, RM; Elsinga, PH; Pruim, J; Hendrikse, HN; Willemsen, ATM; Vaalburg, W
      Quantitative imaging of 5-HT1A receptor binding in healthy volunteers with[F-18]p-MPPF

      NUCLEAR MEDICINE AND BIOLOGY
    33. Rabiner, EA; Gunn, RN; Wilkins, MR; Sargent, PA; Mocaer, E; Sedman, E; Cowen, PJ; Grasby, PM
      Drug action at the 5-HT1A receptor in vivo: Autorecepror and postsynaptic receptor occupancy examined with PET and [carbonyl-C-11]WAY-100635

      NUCLEAR MEDICINE AND BIOLOGY
    34. Andree, B; Halldin, C; Thorberg, SO; Sandell, J; Farde, L
      Use of PET and the radioligand [Carbonyl-C-11]WAY-100635 in psychotropic drug development

      NUCLEAR MEDICINE AND BIOLOGY
    35. Martinez, D; Mawlawi, O; Hwang, DR; Kent, J; Simpson, N; Parsey, RV; Hashimoto, T; Slifstein, M; Huang, YY; Van Heertum, R; Abi-Dargham, A; Caltabiano, S; Malizia, A; Cowley, H; Mann, JJ; Laruelle, M
      Positron emission tomography study of pindolol occupancy of 5-HT1A receptors in humans: Preliminary analyses

      NUCLEAR MEDICINE AND BIOLOGY
    36. Dannon, PN; Sasson, Y; Hirschmann, S; Iancu, I; Grunhaus, LJ; Zohar, J
      Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    37. Rabiner, EA; Gunn, RN; Castro, ME; Sargent, PA; Cowen, PJ; Koepp, MJ; Meyer, JH; Bench, CJ; Harrison, PJ; Pazos, A; Sharp, T; Grasby, PM
      beta-blocker binding to human 5-HT1A receptors in vivo and in vitro: Implications for antidepressant therapy

      NEUROPSYCHOPHARMACOLOGY
    38. Farde, L; Andree, B; Ginovart, N; Halldin, C; Thorberg, SO
      PET-determination of robalzotan (NAD-299) induced 5-HT1A receptor occupancy in the monkey brain

      NEUROPSYCHOPHARMACOLOGY
    39. Khalil, S; Borham, N
      Indirect atomic absorption spectrometric determination of pindolol, propranolol and levamisole hydrochlorides based on formation of ion-associates with ammonium reineckate and sodium cobaltinitrite

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    40. Khalil, S; El-Rabiehi, MM
      Indirect atomic absorption spectrometric determination of pindolol, propranolol and levamisole hydrochlorides based on formation of ion associates with manganese thiocyanate and potassium ferricyanide

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    41. Rojas-Corrales, MO; Ortega-Alvaro, A; Gibert-Rahola, J; Roca-Vinardell, A; Mico, JA
      Pindolol, a beta-adrenoceptor blocker/5-hydroxytryptamine(1A/1B) antagonist, enhances the analgesic effect of tramadol

      PAIN
    42. Kaur, P; Ahlenius, S
      Non-serotonergic potentiation by (-)-pindolol of DOI-induced forward locomotion in rats: possible involvement of beta-adrenoceptors?

      JOURNAL OF NEURAL TRANSMISSION
    43. Marangell, LB
      Augmentation of standard depression therapy

      CLINICAL THERAPEUTICS
    44. von Dadelszen, P; Ornstein, MP; Bull, SB; Logan, AG; Koren, G; Magee, LA
      Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis

      LANCET
    45. Bristow, LJ; O'Connor, D; Watts, R; Duxon, MS; Hutson, PH
      Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100,635, in the rat

      NEUROPHARMACOLOGY
    46. Dawson, LA; Nguyen, HQ
      The role of 5-HT1A and 5-HT1B/1D receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol

      NEUROPHARMACOLOGY
    47. Castro, ME; Harrison, PJ; Pazos, A; Sharp, T
      Affinity of (+/-)-pindolol, (-)-penbutolol, and (-)-tertatolol for pre- and postsynaptic serotonin 5-HT1A receptors in human and rat brain

      JOURNAL OF NEUROCHEMISTRY
    48. Oficialdegui, AM; Martinez, J; Perez, S; Heras, B; Irurzun, M; Palop, JA; Tordera, R; Lasheras, B; del Rio, J; Monge, A
      Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin-1-yl]-1-arylpropane derivatives as potential antidepressants with a dual modeof action: serotonin reuptake inhibition and 5-HT1A receptor antagonism

      FARMACO
    49. Abdel-Hamid, ME
      Comparative LC-MS and HPLC analyses of selected antiepileptics and beta-blocking drugs

      FARMACO
    50. Duxon, MS; Starr, KR; Upton, N
      Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT1A receptor antagonist WAY100635

      BRITISH JOURNAL OF PHARMACOLOGY
    51. Dawson, LA; Nguyen, HQ; Smith, DI; Schechter, LE
      Effects of chronic fluoxetine treatment in the presence and absence of (+/-)pindolol: a microdialysis study

      BRITISH JOURNAL OF PHARMACOLOGY
    52. Fujita, M; Charney, DS; Innis, RB
      Imaging serotonergic neurotransmission in depression: Hippocampal pathophysiology may mirror global brain alterations

      BIOLOGICAL PSYCHIATRY
    53. Martinez, D; Broft, A; Laruelle, M
      Pindolol augmentation of antidepressant treatment: Recent contributions from brain imaging studies

      BIOLOGICAL PSYCHIATRY
    54. Sprouse, J; Braselton, J; Reynolds, L
      5-HT1A agonist potential of pindolol: Electrophysiologic studies in the dorsal raphe nucleus and hippocampus

      BIOLOGICAL PSYCHIATRY
    55. Olver, JS; Cryan, JF; Burrows, GD; Norman, TR
      Pindolol augmentation of antidepressants: a review and rationale

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    56. Arborelius, L; Linner, L; Wallsten, C; Ahlenius, S; Svensson, TH
      Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo

      PSYCHOPHARMACOLOGY
    57. Cousins, MS; Seiden, LS
      The serotonin-1A receptor antagonist WAY-100635 modifies fluoxetine's antidepressant-like profile on the differential reinforcement of low rates 72-sschedule in rats

      PSYCHOPHARMACOLOGY
    58. Cohen, TJ; Cayenne, S; Black, M; Doolittle, S; Ibrahim, B; Quan, WL
      The effects of intrinsic sympathomimetic activity on beta-blocker efficacyfor treatment of neurocardiogenic syncope

      JOURNAL OF INVASIVE CARDIOLOGY
    59. van Niel, MB; Beer, MS; Castro, JL; Cheng, SKF; Evans, DC; Heald, A; Hitzel, L; Hunt, P; Mortishire-Smith, R; O'Connor, D; Watt, AP; MacLeod, AM
      Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT1A and 5-HT re-uptake ligands

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    60. Isaac, M
      Where are we going with SSRIs?

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    61. Yan, HM; Lewander, T
      Differential tissue distribution of the enantiomers of racemic pindolol inthe rat

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    62. Sharma, RP; Singh, V; Janicak, PG; Javaid, JI; Pandey, GN
      The prolactin response to fenfluramine in schizophrenia is associated withnegative symptoms

      SCHIZOPHRENIA RESEARCH
    63. Blier, P; de Montigny, C
      Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders

      NEUROPSYCHOPHARMACOLOGY
    64. Gobert, A; Millan, MJ
      Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone andin association with 5-HT reuptake inhibitors: Comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors

      NEUROPSYCHOPHARMACOLOGY
    65. Smeraldi, E; Benedetti, F; Barbini, B; Campori, E; Colombo, C
      Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression - A placebo-controlled trial

      NEUROPSYCHOPHARMACOLOGY
    66. Clifford, EM; Whale, R; Sharp, T; Cohen, PJ
      Effect of penbutolol on neuroendocrine responses to buspirone and mood in SSRI-refractory patients: A preliminary study

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    67. Wada, Y; Hirao, N; Shiraishi, J; Nakamura, M; Koshino, Y
      Pindolol potentiates the effect of fluoxetine on hippocampal seizures in rats

      NEUROSCIENCE LETTERS
    68. Rosenman, RH; Maser, JD
      Bizarre images and beta-adrenergic blocking agents: A unique case report

      JOURNAL OF PSYCHOACTIVE DRUGS
    69. Montgomery, SA
      New developments in the treatment of depression

      JOURNAL OF CLINICAL PSYCHIATRY
    70. Berman, RM; Charney, DS
      Models of antidepressant action

      JOURNAL OF CLINICAL PSYCHIATRY
    71. Huang, YC; Wu, BN; Lin, YT; Chen, SJ; Chiu, CC; Cheng, CJ; Chen, IJ
      Eugenodilol: A third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta(2)-adrenoceptor agonist-associated vasorelaxant activities

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    72. Cryan, JF; McGrath, C; Leonard, BE; Norman, TR
      Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    73. Kitaori, K; Furukawa, Y; Yoshimoto, H; Otera, J
      CsF in organic synthesis. Regioselective nucleophilic reactions of phenolswith oxiranes leading to enantiopure beta-blockers

      TETRAHEDRON
    74. Millan, MJ; Gobert, A
      (-)-Pindolol increases dialysate concentrations of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely-moving rats

      NEUROPHARMACOLOGY
    75. Fornal, CA; Martin, FJ; Metzler, CW; Jacobs, BL
      Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino) tetralin in awake cats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    76. Brynne, L; Paalzow, LK; Karlsson, MO
      Mechanism-based modeling of rebound tachycardia after chronic I-propranolol infusion in spontaneous hypertensive rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    77. Chidlow, G; Nash, MS; De Santis, LM; Osborne, NN
      The 5-HT1A receptor agonist 8-OH-DPAT lowers intraocular pressure in normotensive NZW rabbits

      EXPERIMENTAL EYE RESEARCH
    78. Arborelius, L; Wallsten, C; Ahlenius, S; Svensson, TH
      The 5-HT1A receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing

      EUROPEAN JOURNAL OF PHARMACOLOGY
    79. Fornal, CA; Martin, FJ; Mendlin, A; Metzler, CW; Bjorvatn, B; Jacobs, BL
      Pindolol increases extracellular 5-HT while inhibiting serotonergic neuronal activity

      EUROPEAN JOURNAL OF PHARMACOLOGY
    80. Moser, PC; Sanger, DJ
      5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    81. Gartside, SE; Clifford, EM; Cowen, PJ; Sharp, T
      Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study

      BRITISH JOURNAL OF PHARMACOLOGY
    82. Ichikawa, J; Meltzer, HY
      The effect of ipsapirone and S(-)-pindolol on dopamine release in rat striatum and nucleus accumbens

      BRAIN RESEARCH
    83. Haddjeri, N; de Montigny, C; Blier, P
      Modulation of the firing activity of rat serotonin and noradrenaline neurons by (+/-)pindolol

      BIOLOGICAL PSYCHIATRY
    84. Berman, RM; Anand, A; Cappiello, A; Miller, HL; Hu, XS; Oren, DA; Charney, DS
      The use of pindolol with fluoxetine in the treatment of major depression: Final results from a double-blind, placebo-controlled trial

      BIOLOGICAL PSYCHIATRY
    85. Andree, B; Thorberg, SO; Halldin, C; Farde, L
      Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomography

      PSYCHOPHARMACOLOGY
    86. Monti, JM; Monti, D
      Functional role of serotonin 5-HT1 and 5-HT2 receptor in the regulation ofREM sleep

      RAPID EYE MOVEMENT SLEEP
    87. BEAL JL; TETT SE
      DETERMINATION OF PINDOLOL ENANTIOMERS IN HUMAN PLASMA AND URINE BY SIMPLE LIQUID-LIQUID-EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Journal of chromatography B. Biomedical sciences and applications
    88. KELSO JR
      PROMOTER PROGNOSTICATION - THE SEROTONIN TRANSPORTER GENE AND ANTIDEPRESSANT RESPONSE

      Molecular psychiatry
    89. SMERALDI E; ZANARDI R; BENEDETTI F; DIBELLA D; PEREZ J; CATALANO M
      POLYMORPHISM WITHIN THE PROMOTER OF THE SEROTONIN TRANSPORTER GENE AND ANTIDEPRESSANT EFFICACY OF FLUVOXAMINE

      Molecular psychiatry
    90. KRISTIANSEN K; EDVARDSEN O; DAHL SG
      MOLECULAR MODELING OF THE ENDOGENOUS PEPTIDE LEU-SER-ALA-LEU, PINDOLOL, 5-HYDROXYTRYPTAMINE AND THEIR INTERACTIONS WITH THE HUMAN 5-HYDROXYTRYPTAMINE(1B) (5-HT1B) RECEPTOR

      Receptors & channels
    91. Dunlop, J; Zhang, YX; Smith, DL; Schechter, LE
      Characterization of 5-HT1A receptor functional coupling in cells expressing the human 5-HT1A receptor as assessed with the cytosensor microphysiometer

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    92. LIPKA E; SPAHNLANGGUTH S; MUTSCHLER E; AMIDON GL
      IN-VIVO NONLINEAR INTESTINAL PERMEABILITY OF CELIPROLOL AND PROPRANOLOL IN CONSCIOUS DOGS - EVIDENCE FOR INTESTINAL SECRETION

      European journal of pharmaceutical sciences
    93. REDROBE JP; BOURIN M
      CLONIDINE POTENTIATES THE EFFECTS OF 5-HT1A, 5-HT1B AND 5-HT2A 2C ANTAGONISTS AND 8-OH-DPAT IN THE MOUSE FORCED SWIMMING TEST/

      European neuropsychopharmacology
    94. Komori, T; Shimoishi, K; Harashima, H; Otagiri, M
      Effects of repeated clarithromycin administration on the pharmacokinetic properties of pindolol in rats

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    95. OLIVEROS L; SENSO A; FRANCO P; MINGUILLON C
      CARBAMATES OF CELLULOSE BONDED ON SILICA-GEL - CHIRAL DISCRIMINATION ABILITY AS HPLC CHIRAL STATIONARY PHASES

      Chirality
    96. NEWMANTANCREDI A; CHAPUT C; GAVAUDAN S; VERRIELE L; MILLAN MJ
      AGONIST AND ANTAGONIST ACTIONS OF (-)PINDOLOL AT RECOMBINANT, HUMAN SEROTONIN(1A) (5-HT1A) RECEPTORS

      Neuropsychopharmacology
    97. STOCKMEIER CA; SHAPIRO LA; DILLEY GE; KOLLI TN; FRIEDMAN L; RAJKOWSKA G
      INCREASE IN SEROTONIN-1A AUTORECEPTORS IN THE MIDBRAIN OF SUICIDE VICTIMS WITH MAJOR DEPRESSION - POSTMORTEM EVIDENCE FOR DECREASED SEROTONIN ACTIVITY

      The Journal of neuroscience
    98. SOMMERS DK; VANWYK M; SNYMAN JR
      INFLUENCE OF ANTAGONISM AT 5-HT1A AUTORECEPTORS ON DEXFENFLURAMINE-INDUCED PROLACTIN-RELEASE DURING TREATMENT WITH FLUOXETINE

      Medical science research
    99. Redrobe, JP; Bourin, M; Colombel, MC; Baker, GB
      Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms

      JOURNAL OF PSYCHOPHARMACOLOGY
    100. BELL C; WILSON S; NUTT DJ
      PINDOLOL AUGMENTATION OF SERTRALINE IN RESISTANT DEPRESSION AND ITS EFFECT ON SLEEP

      JOURNAL OF PSYCHOPHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 19:24:10